| Copper sulfide perfluorocarbon nanodroplets as clinically relevant photoacoustic/ultrasound imaging agents DY Santiesteban, DS Dumani, D Profili, SY Emelianov Nano letters 17 (10), 5984-5989, 2017 | 79 | 2017 |
| Monitoring/imaging and regenerative agents for enhancing tissue engineering characterization and therapies DY Santiesteban, K Kubelick, KS Dhada, D Dumani, L Suggs, ... Annals of biomedical engineering 44, 750-772, 2016 | 26 | 2016 |
| Color-coded perfluorocarbon nanodroplets for multiplexed ultrasound and photoacoustic imaging DY Santiesteban, KA Hallam, SK Yarmoska, SY Emelianov Nano research 12, 741-747, 2019 | 23 | 2019 |
| A phase I/II clinical trial of the reversible LSD1 inhibitor, seclidemstat, in patients with relapsed/refractory Ewing sarcoma. DR Reed, L Mascarenhas, PA Meyers, SP Chawla, DJ Harrison, B Setty, ... Journal of Clinical Oncology 38 (15_suppl), TPS11567-TPS11567, 2020 | 8 | 2020 |
| Phase 1 trial of seclidemstat (SP-2577) in patients with relapsed/refractory Ewing sarcoma. DR Reed, SP Chawla, B Setty, L Mascarenhas, PA Meyers, J Metts, ... Journal of Clinical Oncology 39 (15_suppl), 11514-11514, 2021 | 7 | 2021 |
| Preliminary efficacy from an ongoing phase 1 dose escalation study of seclidemstat (SP-2577) in patients (pts) with advanced solid tumors (AST). SP Chawla, VS Chua-Alcala, JC Sachdev, DS Wages, DD Stenehjem, ... Journal of Clinical Oncology 39 (15_suppl), 3073-3073, 2021 | 2 | 2021 |
| Phase 1 expansion trial of the LSD1 inhibitor seclidemstat (SP-2577) with and without topotecan and cyclophosphamide (TC) in patients (pts) with relapsed or refractory Ewing … DR Reed, SP Chawla, B Setty, L Mascarenhas, PA Meyers, J Metts, ... Journal of Clinical Oncology 39 (15_suppl), TPS11577-TPS11577, 2021 | 2 | 2021 |
| SP-3164, a novel cereblon-binding protein Degrader, shows activity in preclinical lymphoma models DY Santiesteban, AD Duncan, NQ Mirza, V Jacques, S DeWitt, SP Iyer Blood 140 (Supplement 1), 8865-8866, 2022 | 1 | 2022 |
| Abstract P087: Targeting LSD1 protein scaffolding function in FET-rearranged sarcomas with SP-2577 G Rask, ER Theisen, AD Duncan, DY Santiesteban Molecular Cancer Therapeutics 20 (12_Supplement), P087-P087, 2021 | 1 | 2021 |
| Copper Sulfide Perfluorocarbon Nanocarriers DY Santiesteban, DS Dumani, S Emelianov US Patent App. 16/274,982, 2019 | 1 | 2019 |
| P1241: A NOVEL CEREBLON-BINDING MOLECULAR GLUE, SP-3164, SHOWS PRECLINICAL ACTIVITY IN NON-HODGKIN LYMPHOMAS D Santiesteban, AD Duncan, NQ Mirza, S Horrigan, S Dewitt, V Jacques, ... HemaSphere 7 (S3), e95971dd, 2023 | | 2023 |
| SP-3164, a novel molecular glue degrader with activity in preclinical models of multiple myeloma AD Duncan, DY Santiesteban, NQ Mirza, S Horrigan, S DeWitt, V Jacques, ... Cancer Research 83 (7_Supplement), 6253-6253, 2023 | | 2023 |
| SP-3164, a novel ikaros and aiolos molecular glue degrader with preclinical activity in non-Hodgkin lymphomas DY Santiesteban, AD Duncan, NQ Mirza, S DeWitt, V Jacques, S Horrigan, ... Cancer Research 83 (7_Supplement), 524-524, 2023 | | 2023 |
| 13P Transcriptional profiling of FET-rearranged sarcomas in response to SP-2577 G Rask, E Theisen, A Duncan, D Santiesteban Annals of Oncology 33, S7-S8, 2022 | | 2022 |
| Methods of inhibiting lysine-specific demethylase 1 (lsd-1) S Blumberg, J Bohmann, AD Duncan, S Horrigan, B McCreedy, ... US Patent App. 17/385,508, 2022 | | 2022 |
| Notice of Removal: Multicolor perfluorocarbon nanodroplets for multiplexed ultrasound and photoacoustic imaging D Santiesteban, K Hallam, S Yarmoska, S Emelianov 2017 IEEE International Ultrasonics Symposium (IUS), 1-1, 2017 | | 2017 |
| Perfluorocarbon Nanodroplets as Oxygen Carriers for Improved Stem Cell Angiogenic Therapies DY Santiesteban, AS Hannah, L Suggs, S Emelianov TISSUE ENGINEERING PART A 21, S219-S219, 2015 | | 2015 |
